The agreement with AstraZeneca/MedImmune aims at establishing the conditions for selection and funding of scientific and technological research involving collaboration between scientists working in public or private research or teaching institutions in the State of São Paulo and/or scientists from the AZ or MedImmune and its Affiliates.
Send your message by email
Advanced search
AstraZeneca/MedImmune
- Fonds de Recherche du Québec (FRQ)
- Centro para el Desarrollo Tecnológico Industrial (CDTI)
- Comisión Nacional de Investigación Científica y Tecnológica (CONICYT)
- Danish Agency for Science and Higher Education
- Duke University
- Equinor (former Statoil)
- EU-CELAC IG (former ERA.Net - LAC)
- EU-LIFE
- Global Alliance for Chronic Diseases (GACD)
- Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
- Grupo São Martinho
- INCOBRA
- See more FAPESP Cooperation Partnerships and Agreements
Research grants
- Characterization of the optimal hiPSC-derived cardiac cell population for heart regeneration after myocardial infarction, AP.PITE
Abstract
The main goal of this project is to characterize the optimal hiPSC-derived cell population for cardiac regeneration after MI, using a preclinical model of Ml in pigs. First, human iPSCs will be generated from either human fibroblasts or urine samples using a non-integrative reprogramming strategy based on episomal transfection. hiPSCs will be characterized to ensure they show the typical …
Total / Available in English
| 1 / 1 | Completed research grants |
| Associated processes | |
Carregando Filtros. Aguarde...
Left-click and hold. Drag the cursor on the map until you see the view you want.
Select options:
Select year: |
Show years by sequential order |